60 Degrees Pharmaceuticals(SXTP)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $0.96 (-3.69%), 시가총액 $0.00B, 52주 최저~최고 $0.47 ~ $5.20.
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal and pneumocystis pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue fever. It also has patent license agreement with Tufts Medical Center to jointly advance the development and comme
60 Degrees Pharmaceuticals의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
60 Degrees Pharmaceuticals의 현재 주가는 $0.96 (-3.69%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
60 Degrees Pharmaceuticals의 시가총액은 약 $0.00B입니다.
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the Unite